You are here: Industry Insights > GSK

News List

Thermo Fisher Buys GSK API Site for $100M contractpharma
May 17, 2019
Expands complex API manufacturing footprint with acquisition of site in Ireland.
Vectura wins patent litigation battle against GSK, awarded $89.7M pharmatimes
May 09, 2019
Vectura has confirmed that it has won the US GlaxoSmithKline (GSK) patent litigation trial and has been awarded $89.7million in damages by the trial jury.
New MenB awareness drive backs up vaccine makers GSK, Pfizer fiercepharma
May 06, 2019
Meningitis B vaccine makers GlaxoSmithKline and Pfizer have been running awareness campaigns for years, yet vaccination rates remain stagnant.
GSK chases Trelegy asthma nod with mixed phase 3 results fiercepharma
May 06, 2019
With generics attacking Advair, GlaxoSmithKline has talked up prospects for 3-in-1 respiratory med Trelegy. Now, the company has data in hand that could help it move into the asthma arena—though it's not all positive.
GSK Receives US Approval of Benlysta for Intravenous Use in Children with Lupus Aged Five Years and Above drugs
April 28, 2019
London UK, Philadelphia USA April 26, 2019 -- GSK today announced that the US Food and Drug Administration (FDA) has approved, under priority review, the use of the intravenous (IV) formulation of Benlysta (belimumab) ...
Novartis recruits GSK exec as new Sandoz CEO pharmatimes
April 25, 2019
Novartis has announced that GlaxoSmithKline’s current vice president of classic and established products, commercial and digital platforms has joined the company as chief executive of its Sandoz unit.
Novartis brings in GlaxoSmithKline's Richard Saynor to lead turnaround of Sandoz unit firstwordpharma
April 25, 2019
Novartis announced Wednesday alongside its first-quarter financial results, that Richard Saynor, the current senior vice president of classic and established products ...
Fulcrum acquires global rights of investigational drug losmapimod from GSK pharmaceutical-business-review
April 24, 2019
Fulcrum Therapeutics has acquired all worldwide development and commercialization rights of investigational drug losmapimod from GlaxoSmithKline (GSK).
Malawi launches pilot of world’s first malaria vaccine pharmaceutical-technology
April 24, 2019
Malawi launches pilot of world’s first malaria vaccine.
GSK to make redundancies at plant in Stevenage pharmafile
April 17, 2019
GSK to make redundancies at plant in Stevenage.

Previous page 1 2 3 4 5 6 7 8 9 10 ... 40 41 Next page